THE MCMANUS GROUP

Lobbying for ZIMMER BIOMET · A global leader in musculoskeletal healthcare.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Indiana · House · Senate · $50,000.00 income · posted Apr 21, 2025

Lobbying activity 3

Medicare/Medicaid

Access and reimbursement of medical devices in Medicare program. Issues related to capping beneficiary copayments for Medicare beneficiaries in ambulatory surgery centers.

Health Issues

Issues related to Artificial Intelligences approval in Medical Devices.

Taxation/Internal Revenue Code

Issues related to corporate tax policy, including the corporate tax rate, R&D expensing, FDII extension, and implementation of the OECD global minimum tax (Pillar II).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.